Top news of the week: 11.04.2022.
Healthcare
Can We Make a Pill to End the Pandemic? Contributed Opinion
Vision and Value discusses the state of the virus and big pharma's race to slow the death rate as well as the spread of the pandemic — and what it means for investors.
What Person-Centered Interoperability Looks Like: Seqster
He had me at the statement, “I believe health data is medicine.” Those were the words of Ardy Arianpour, CEO and Co-Founder of Seqster, when sharing with me how his company was founded. ...
Upskilling in a digital health world
It’s no secret that digital technologies are playing a significant role when it comes to shaping the next era of healthcare. Necessity accelerated the adoption of new and sophisticated ...
We are delighted to announce that Abingworth LLP will become part of The Carlyle Group
Carlyle Expands Leading Healthcare Franchise with Agreement to Acquire Life Sciences Investment Firm Abingworth NEW YORK, NY – Global investment firm Carlyle (NASDAQ: CG) …
25 Digital Health Influencers To Follow in 2022
Connect with people that are changing digital health, this list of 25 digital health influencers to follow is a great place to start
Solving the puzzle of rare diseases through international collaboration
Close to 300 million people around the world have a rare disease (RD) today, but there is good reason to hope that the root causes of genetic RD – most rare diseases are genetic – will ...
Biopharma Co. Begins Dosing in Ph. 1 Solid Tumor Trial Trending Company
NGM Biopharmaceuticals Inc. shares rose 14.75% after the company reported it dosed the first group of patients in its Phase 1/1b clinical trial of NGM831 for use in treating advanced solid ...
Personalised blood test could help predict which lung cancers might return
Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.